117 related articles for article (PubMed ID: 26924325)
1. Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?
Siniscalchi A; Sanguigni S; Lochner P; De Sarro G; Malferrari G; Gallelli L
Curr Vasc Pharmacol; 2016; 14(3):302-3. PubMed ID: 26924325
[No Abstract] [Full Text] [Related]
2. Cardioembolic stroke in the THRombolysis and STatins (THRaST) study.
Cappellari M; Bovi P; Toni D; Micheletti N; Tomelleri G; Carletti M; Moretto G
Int J Stroke; 2015 Feb; 10(2):E22. PubMed ID: 25598034
[No Abstract] [Full Text] [Related]
3. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!
Scheitz JF; Nolte CH; Endres M
Stroke; 2013 May; 44(5):1472-6. PubMed ID: 23444304
[No Abstract] [Full Text] [Related]
4. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.
Montaner J
Stroke; 2008 Jan; 39(1):e6. PubMed ID: 18048844
[No Abstract] [Full Text] [Related]
5. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009].
Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J
Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634
[TBL] [Abstract][Full Text] [Related]
6. Editorial comment--outcome of acute stroke patients without visible occlusion on early arteriography.
Schellinger PD
Stroke; 2004 May; 35(5):1139-40. PubMed ID: 15073399
[No Abstract] [Full Text] [Related]
7. The neurovascular unit and combination treatment strategies for stroke.
Zhang L; Zhang ZG; Chopp M
Trends Pharmacol Sci; 2012 Aug; 33(8):415-22. PubMed ID: 22595494
[TBL] [Abstract][Full Text] [Related]
8. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
9. Fluctuation of diffusion-weighted imaging and apparent diffusion coefficient in acute stroke following tissue plasminogen activator administration.
Chertcoff AS; Chomont J; Bandeo L; Pantiu F; Roca CU; Bonardo P; Rugilo C; Reisin R
Neurol India; 2017; 65(4):889-890. PubMed ID: 28681774
[No Abstract] [Full Text] [Related]
10. Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke.
Geng J; Song Y; Mu Z; Xu Q; Shi G; Sun Y; Chen Y; Lin Y; Pan Y; Yu L; Yang GY; Li Y
Acta Neurochir Suppl; 2016; 121():269-75. PubMed ID: 26463960
[TBL] [Abstract][Full Text] [Related]
11. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
Finnigan SP; Rose SE; Chalk JB
Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
[No Abstract] [Full Text] [Related]
12. Thrombolysis May Reduce the Incidence/Extent of Postprocedural Ischemic Strokes Associated With Carotid Artery Stenting: A Hypothesis.
Paraskevas KI; Veith FJ
Angiology; 2015 Aug; 66(7):604-6. PubMed ID: 25168957
[No Abstract] [Full Text] [Related]
13. Tissue plasminogen activator approved for stroke.
Barber A; Gommans J
N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
[No Abstract] [Full Text] [Related]
14. Use of tissue plasminogen activator to treat acute ischemic stroke.
Alexandrov AW
Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
[No Abstract] [Full Text] [Related]
15. The hard way to acute stroke treatment.
Sironi L; Gelosa P; Tremoli E; Cimino M
J Hypertens; 2008 Dec; 26(12):2274-5. PubMed ID: 19008704
[No Abstract] [Full Text] [Related]
16. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke.
Docagne F; Parcq J; Lijnen R; Ali C; Vivien D
Stroke; 2015 Jan; 46(1):314-20. PubMed ID: 25395410
[No Abstract] [Full Text] [Related]
17. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Liao X; Wang Y; Wang Y
Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
[No Abstract] [Full Text] [Related]
18. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
Coutts SB; Hill MD
Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
[No Abstract] [Full Text] [Related]
19. Alteplase for ischaemic stroke.
Burrage D
Lancet; 2014 Oct; 384(9953):1502. PubMed ID: 25390573
[No Abstract] [Full Text] [Related]
20. Chronic kidney disease and stroke.
El Husseini N; Kaskar O; Goldstein LB
Adv Chronic Kidney Dis; 2014 Nov; 21(6):500-8. PubMed ID: 25443575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
